Sequential therapies in metastatic renal cell carcinoma: option or strategy?
- PMID: 18778889
- DOI: 10.1016/j.eururo.2008.08.066
Sequential therapies in metastatic renal cell carcinoma: option or strategy?
Comment on
-
Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysis.Eur Urol. 2008 Dec;54(6):1373-8. doi: 10.1016/j.eururo.2008.07.051. Epub 2008 Aug 8. Eur Urol. 2008. PMID: 18692304
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
